Linked Data API

Show Search Form

Search Results

229124
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Dermatology more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what his Department's (a) direct and (b) indirect involvement in (i) the procurement of dermatology services from Nottingham University Hospitals Trust to Circle in 2007 and (ii) the reprocurement of those services in 2012; and whether that involvement was in an advisory capacity. more like this
tabling member constituency Nottingham South more like this
tabling member printed
Lilian Greenwood more like this
uin 228787 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>The original contract for the Nottingham Treatment Centre was signed in July 2005 between the Secretary of State for Health, the local primary care trusts (PCTs) and Circle after approval of a business case for the scheme by the Department. The services provided by the Treatment Centre include dermatology. The Treatment Centre became operational in July 2008 after construction completion.</p><p> </p><p> </p><p> </p><p>The Department was not involved directly or indirectly in the reprocurement of the services. On 1 April 2013 the Department’s responsibility under the contract passed to NHS England. The reprocurement was managed locally by the clinical commissioning group and the local area team of NHS England; the contract was awarded to Circle after a competitive procurement process.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-26T11:08:15.673Zmore like thismore than 2015-03-26T11:08:15.673Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4029
label Biography information for Lilian Greenwood more like this
229132
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hearing Impairment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much the NHS has spent on audiology services in each of the last five years. more like this
tabling member constituency Croydon North more like this
tabling member printed
Mr Steve Reed more like this
uin 228770 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>Information on spend for audiology services and specific procedures for hearing problems are not available in the format requested. The following table provides NHS programme budgeting figures on ‘problems of hearing’ for the five year period 2008-09 to 2012-13, which is the latest available data.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>2008-09</p></td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td></tr><tr><td><p>Expenditure (£ billion)</p></td><td><p>0.42</p></td><td><p>0.50</p></td><td><p>0.45</p></td><td><p>0.46</p></td><td><p>0.46</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>More information about programme budgeting data can be found on the NHS England website at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/resources/resources-for-ccgs/prog-budgeting/" target="_blank">http://www.england.nhs.uk/resources/resources-for-ccgs/prog-budgeting/</a></p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p>
answering member constituency North Norfolk more like this
answering member printed Norman Lamb more like this
grouped question UIN 228771 more like this
question first answered
less than 2015-03-26T13:04:11.037Zmore like thismore than 2015-03-26T13:04:11.037Z
answering member
1439
label Biography information for Norman Lamb more like this
tabling member
4268
label Biography information for Steve Reed more like this
229151
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Leukaemia: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of NICE's decision not to appraise the drug ponatinib for chronic myeloid leukaemia; and if he will make a statement. more like this
tabling member constituency Alyn and Deeside more like this
tabling member printed
Mark Tami more like this
uin 228644 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p><strong> </strong></p><p> </p><p>The National Institute for Health and Care Excellence (NICE) considered the suitability of ponatinib for the treatment of chronic myeloid leukaemia for referral to its technology appraisal work programme through the topic selection process in 2013-14. NICE concluded, following consultation with stakeholders, that a technology appraisal was not appropriate, noting that the likely eligible patient population was very small. Further information on the rationale for not referring this topic to NICE is available on the NICE website at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/block-scoping-reports" target="_blank">http://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/block-scoping-reports</a></p><p> </p><p> </p><p> </p><p>A number of treatments, including the drug bosutinib, are available through the Cancer Drugs Fund for patients with chronic myeloid leukaemia who are intolerant or resistant to other tyrosine-kinase inhibitor therapies.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN 228645 more like this
question first answered
less than 2015-03-26T11:23:31.313Zmore like thismore than 2015-03-26T11:23:31.313Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1383
label Biography information for Mark Tami more like this
229159
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Ovarian Hyperstimulation Syndrome more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, with reference to the Answers of 2 December 2014 to Question HL2907 and 17 March 2015 to Question HL5319 and the Written Statement of 24 November 2010, Official Report, columns WS101-2, on Questions for Written Answer: Correction, how many incidents of hospitalisation due to ovarian hyperstimulation syndrome (OHSS) have been reported to the Human Fertilisation and Embryology Authority (HFEA); what steps the HFEA takes to ensure that any suspected serious adverse reactions are reported to the licensing authority in accordance with the Human Medicines Regulations 2012; what steps the HFEA takes in cases of failure to report any such incidents to the Medicines and Healthcare Products Regulatory Agency; and whether he is satisfied that the HFEA is doing enough to protect patients from OHSS. more like this
tabling member constituency Congleton more like this
tabling member printed
Fiona Bruce more like this
uin 228699 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>The information the Human Fertilisation and Embryology Authority (HFEA) holds on number of incidents of hospitalisation due to ovarian hyperstimulation syndrome (OHSS), that have been reported to the Authority, is set out in the written answer provided to the then hon. Member for Heywood and Middleton on 24 June 2014, <em>Official Report,</em> columns 156-157W (UIN 201565).</p><p> </p><p> </p><p> </p><p>The HFEA has advised that the responsibility for reporting adverse reactions in accordance with the Human Medicines Regulations 2012 rests with clinics and the treating clinician. Should the HFEA be made aware of information relevant to the regulatory functions of the Medicines and Healthcare products Regulatory Agency, this information would be shared between the two organisations.</p><p> </p><p> </p><p> </p><p>The Department is satisfied that the Authority is fulfilling its statutory duties as set out in the Human Fertilisation and Embryology Act 1990, as amended.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-26T11:28:01.6Zmore like thismore than 2015-03-26T11:28:01.6Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
3958
label Biography information for Fiona Bruce more like this
229166
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Medical Records: Databases more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, by what date he plans to start patient communications in care.data pathfinder areas on the implications for patients of that programme to begin. more like this
tabling member constituency Birmingham, Hall Green more like this
tabling member printed
Mr Roger Godsiff more like this
uin 228664 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>No patient communications will occur until the independent expert Dame Fiona Caldicott, as National Data Guardian, has reviewed them and provided advice.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-26T14:22:17.123Zmore like thismore than 2015-03-26T14:22:17.123Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
304
label Biography information for Mr Roger Godsiff more like this
229170
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hospital Beds: East Midlands more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many hospital beds in each sector or service there have been in (a) Sherwood Forest Hospitals and (b) Nottingham University Hospitals NHS Foundation Trusts in each year since 2008. more like this
tabling member constituency Ashfield more like this
tabling member printed
Gloria De Piero more like this
uin 228754 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>Data on beds open overnight or day only is routinely collected and data since 2000-01 is published online at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/" target="_blank">http://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/</a></p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-26T14:19:12.273Zmore like thismore than 2015-03-26T14:19:12.273Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
3915
label Biography information for Gloria De Piero more like this
229176
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Medical Equipment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what part consultation and stakeholder engagement will play in NHS England's review of regulations relating to dispensing appliance contractor licences. more like this
tabling member constituency Knowsley more like this
tabling member printed
Mr George Howarth more like this
uin 228749 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-26more like thismore than 2015-03-26
answer text <p>NHS England currently has no plans to ask the Department to consider making any changes in respect of those provisions of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, as amended, that relate to dispensing appliance contractors. If NHS England were to undertake a review of the regulatory arrangements concerning dispensing appliance contractors, it would take account of a range of factors including the views of patients, consumers and business.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN
228746 more like this
228747 more like this
228748 more like this
question first answered
less than 2015-03-26T14:22:34.77Zmore like thismore than 2015-03-26T14:22:34.77Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
481
label Biography information for Sir George Howarth more like this
229258
registered interest false more like this
date less than 2015-03-23more like thismore than 2015-03-23
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Research more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what research reports his Department has commissioned from external bodies between September 2010 and December 2014 have not been published; when each such report was commissioned; what the nature of the research commissioned for each report was; from whom each such research report was commissioned; what the value of each such commission was; on what date each such report was received by his Department; for what reason each such research report has not yet been published; and when he plans to publish each such report. more like this
tabling member constituency Sheffield South East more like this
tabling member printed
Mr Clive Betts more like this
uin 228818 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-25more like thismore than 2015-03-25
answer text <p>The Department funds research through the National Institute for Health Research (NIHR) and the Department’s Policy Research Programme (PRP). The NIHR’s policy statement on open access for its funded research can be found on the NIHR website:</p><p> </p><p> </p><p> </p><p><a href="http://www.nihr.ac.uk/policy-and-standards/nihr-policy-on-open-access-for-its-funded-research.htm" target="_blank">http://www.nihr.ac.uk/policy-and-standards/nihr-policy-on-open-access-for-its-funded-research.htm</a></p><p> </p><p> </p><p> </p><p>Details of commissioned and researcher-led projects funded through programmes managed by the NIHR Evaluation, Trials and Studies Coordinating Centre can be found on the centre’s website:</p><p> </p><p> </p><p> </p><p><a href="http://www.nets.nihr.ac.uk/projects?collection=netscc&amp;meta_P_sand=Project" target="_blank">http://www.nets.nihr.ac.uk/projects?collection=netscc&amp;meta_P_sand=Project</a></p><p> </p><p><strong> </strong></p><p> </p><p>These details include research summary, contractor, cost, start date, estimated date of publication, and links to commissioning briefs and published reports.</p><p> </p><p><strong> </strong></p><p> </p><p>Details of projects, initiatives and long-term programmes of research currently funded by the PRP are available on the website of the PRP Central Commissioning Facility:</p><p> </p><p> </p><p> </p><p><a href="http://www.prp-ccf.org.uk/" target="_blank">http://www.prp-ccf.org.uk/</a></p><p> </p><p> </p><p> </p><p>These details include research summary, contractor, start date, and estimated date of completion. Cost will be included in future updates. The website also has links to summary final reports received since April 2011.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-25T17:28:13.833Zmore like thismore than 2015-03-25T17:28:13.833Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
394
label Biography information for Mr Clive Betts more like this
228868
registered interest false more like this
date less than 2015-03-20more like thismore than 2015-03-20
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hepatitis: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, pursuant to the Answers of 27 February 2015 to Questions 225235 and 225238, by what process NHS England is developing the interim commissioning policies referred to in those Answers; whether funding has been allocated to support those policies; and whether those policies have been discussed by the Clinical Priorities Advisory Group. more like this
tabling member constituency Liverpool, Wavertree more like this
tabling member printed
Luciana Berger more like this
uin 228635 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-25more like thismore than 2015-03-25
answer text <p>NHS England’s process for developing interim commissioning policies involves evidence review, recommendation development, and service and financial impact assessment.</p><p> </p><p> </p><p> </p><p>NHS England’s Clinical Reference Groups (CRGs), Public Health England and other stakeholders are involved in these processes.</p><p> </p><p> </p><p> </p><p>The recommendations of CRGs are considered by the relevant Programme of Care Board and then the Clinical Priorities Advisory Group (CPAG).</p><p> </p><p> </p><p> </p><p>The draft interim policy for treatment of hepatitis C in patients with cirrhosis is following this process. NHS England has advised that it will be considered by the Programme of Care Board at the end of March and then by CPAG.</p><p> </p><p> </p><p> </p><p>The financial impact assessment of the interim policy is continuing. This will inform the decision on financial planning that NHS England will take with regard to this policy.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-25T16:20:42.6Zmore like thismore than 2015-03-25T16:20:42.6Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4036
label Biography information for Luciana Berger more like this
228571
registered interest false more like this
date less than 2015-03-19more like thismore than 2015-03-19
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Prescriptions: Fees and Charges more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what the change in prescription charges has been in real terms in each year since 2009-10. more like this
tabling member constituency Chesterfield more like this
tabling member printed
Toby Perkins more like this
uin 228320 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-24more like thismore than 2015-03-24
answer text <p>Information is provided in the table.</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td colspan="8"><p>Annual prescription charge increase per item dispensed, in England, in real terms, 2009 to 2015</p></td></tr><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td></tr><tr><td><p>Gross Domestic Product (GDP) deflator: year on year growth (%)</p></td><td><p>2.6</p></td><td><p>2.8</p></td><td><p>1.8</p></td><td><p>1.7</p></td><td><p>2.1</p></td><td><p>1.7</p></td><td><p>1.4</p></td></tr><tr><td><p>Prescription charge per item dispensed (£)</p></td><td><p>7.20</p></td><td><p>7.20</p></td><td><p>7.40</p></td><td><p>7.65</p></td><td><p>7.85</p></td><td><p>8.05</p></td><td><p>8.20</p></td></tr><tr><td><p>Increase in prescription charge (%)</p></td><td><p>-</p></td><td><p>0.0</p></td><td><p>2.8</p></td><td><p>3.4</p></td><td><p>2.6</p></td><td><p>2.5</p></td><td><p>1.9</p></td></tr><tr><td><p>Real increase in prescription charge (%)</p></td><td><p>-</p></td><td><p>-2.7</p></td><td><p>1.0</p></td><td><p>1.7</p></td><td><p>0.5</p></td><td><p>0.8</p></td><td><p>0.5</p><p> </p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The GDP deflators for 2014/15 and 2015/16 are based on Office for Budget Responsibility forecasts published in <em>the Economic and Fiscal Outlook</em> (March 2015)</p><p> </p><p> </p><p> </p><p>The cost of a three-month Prescription Pre-payment Certificate (PPC) has been frozen since 2011/12 and the 12-month PPC has been frozen since 2009/10. 90% of items are dispensed free.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-24T17:31:48.123Zmore like thismore than 2015-03-24T17:31:48.123Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
3952
label Biography information for Mr Toby Perkins more like this